Keros Therapeutics Inc (NASDAQ:KROS) Up 9.24% Over A Week, Now Can The Stock Hit Well Above $1.21?
In last trading session, Keros Therapeutics Inc (NASDAQ:KROS) saw 1.22 million shares changing hands with its beta currently measuring 1.16. Company’s recent per share price